Base: $193,898 to $290,847; bonus/equity: eligible...
4+ years pharmaceutical hcp marketing experience
Proven track record of market execution against kpis
Experience leading launches and new asset introductions
This role involves shaping and executing the U.S. integrated strategy for EGFR-mutated lung cancer across the treatment paradigm
Job Summary
This role involves shaping and executing the U.S. integrated strategy for EGFR-mutated lung cancer across the treatment paradigm.
The position offers the opportunity to help redefine the treatment paradigm for patients with EGFR-mutated lung cancer within an industry-leading Oncology portfolio.
AstraZeneca fosters a culture of dedication, accountability, innovation, and shared ownership while offering competitive compensation including short-term incentives and equity-based awards.
Matching Summary
This role involves shaping and executing the U.S. integrated strategy for EGFR-mutated lung cancer across the treatment paradigm.
Salary
Base: $193,898 to $290,847; Bonus/Equity: Eligible for short-term incentive bonuses and equity-based awards; Benefits: Qualified retirement programs, paid time off, health, dental, and vision coverage
Skills & Requirements
Must-have
4+ years pharmaceutical HCP marketing experience
Proven track record of market execution against KPIs
Experience leading launches and new asset introductions
Nice-to-have
Prior marketing experience in lung cancer or EGFR
People leadership experience with talent development
Deep experience in U.S. Oncology market
Key Requirements
Bachelor's degree in relevant field
4+ years pharmaceutical in-line HCP marketing experience